U.S. Building Stock News

EZCORP (EZPW) opened Q1 2026 with revenue of US$382.0 million and basic EPS of US$0.72, setting a clear marker against a trailing twelve month EPS of US$2.08 and total revenue of about US$1.3 billion. Over the past year, the company has seen quarterly revenue move from US$320.2 million in Q1 2025 to US$382.0 million in Q1 2026, while quarterly EPS shifted from US$0.57 to US$0.72, with trailing net income reaching US$122.9 million. Trailing net margins are now at 9.2% compared with 7.2% a year...

Modine Manufacturing (MOD) has posted a mixed Q3 2026 update, with revenue at US$805 million and a basic EPS loss of US$0.90, alongside trailing twelve month basic EPS of US$1.86 on revenue of US$2.9 billion. The company has seen quarterly revenue move from US$616.8 million and EPS of US$0.78 in Q3 2025 to US$805 million and a loss in Q3 2026. Over the same period, trailing twelve month revenue has ranged between US$2.5 billion and US$2.9 billion, with EPS between US$1.86 and US$3.57,...

ePlus (PLUS) has just reported Q3 2026 results with revenue of US$614.8 million and basic EPS of US$1.28, set against trailing twelve month revenue of about US$2.4 billion and EPS of US$5.27 that came alongside a 53.7% rise in earnings over the past year. The company has seen revenue move from US$498.1 million and EPS of US$0.96 in Q4 2025 to between roughly US$608.8 million and US$637.3 million, with EPS ranging from US$1.03 to US$1.45 across the first three quarters of 2026. With net margin...

Selective Insurance Group director increased a personal stake in the company through a recent share purchase. The transaction coincides with board approved amendments to the company’s bylaws on director eligibility and leadership responsibilities. The combination of insider buying and governance updates is drawing attention from existing shareholders and potential investors. Selective Insurance Group, traded as NasdaqGS:SIGI, is drawing fresh interest after this insider move at a share...

Polaryx Therapeutics (PLYX) has drawn investor attention after a sharp 28.9% single day share price decline, with the stock closing at US$16. This move comes against a year to date return of negative 54.3%. See our latest analysis for Polaryx Therapeutics. The sharp 28.9% single day share price return decline and the year to date share price return of 54.3% point to fading momentum, suggesting that recent moves reflect shifting risk perception more than steady longer term sentiment. If...

Clinical and financing moves put Sangamo Therapeutics (SGMO) in focus Sangamo Therapeutics (SGMO) moved into the spotlight after releasing detailed Phase 1/2 STAAR study data for its Fabry gene therapy candidate, alongside a US$25 million follow on equity offering and a change in its finance leadership. See our latest analysis for Sangamo Therapeutics. Against this backdrop of clinical data, financing and leadership change, Sangamo Therapeutics’ share price has been under pressure, with a 30...

In recent days, Endava reiterated its emphasis on complex digital transformation projects while issuing conservative guidance that reflects slower revenue growth and cautious enterprise demand. This shift in tone has prompted a more reserved stance from analysts, who are reassessing the company’s risk profile and longer-term growth narrative. With conservative guidance underscoring slower revenue growth, we’ll now examine how this development reshapes Endava’s broader investment narrative...

There's no doubt that money can be made by owning shares of unprofitable businesses. For example, although Amazon.com...

AGCO Corporation ( NYSE:AGCO ) has announced that it will pay a dividend of $0.29 per share on the 16th of March...

The subdued stock price reaction suggests that Extreme Networks, Inc.'s ( NASDAQ:EXTR ) strong earnings didn't offer...

Duolingo, Inc. ( NASDAQ:DUOL ) shareholders that were waiting for something to happen have been dealt a blow with a 37...

Enphase Energy, Inc. ( NASDAQ:ENPH ) shares have continued their recent momentum with a 52% gain in the last month...

National Vision Holdings, Inc. ( NASDAQ:EYE ) shareholders may have reason to be concerned, as several insiders sold...

Key Insights Lindsay's estimated fair value is US$144 based on 2 Stage Free Cash Flow to Equity Lindsay's US$132 share...

Most readers would already be aware that Telephone and Data Systems' (NYSE:TDS) stock increased significantly by 21...

If you are trying to figure out whether Gold Royalty is genuinely good value or just riding hype, starting with a clear view of its current valuation is essential. Gold Royalty's share price, last seen at US$4.35, has had mixed short term moves, with a 10.3% decline over the last 7 days, a 4.3% gain over 30 days, and returns of 6.6% year to date and 191.9% over the past year. Recent commentary around Gold Royalty has focused on its position within the gold royalty space and investor interest...

If you are trying to work out whether BioStem Technologies at around US$5.95 is attractively priced or not, you are in the right place. The share price has been volatile recently, with a 51.3% gain over the last 30 days, a 22.6% decline over the last week, a 52.3% gain year to date, and a 67.1% decline over the last year, alongside very large gains over 3 and 5 years. These sharp moves have come as investors react to ongoing developments around the company and its position in the...

What the recent price move might mean for First Watch Restaurant Group (FWRG) First Watch Restaurant Group (FWRG) has drawn fresh attention after a recent share price move, with the stock closing at $17.24 and sitting on a month return of about 7% and year to date gain near 12%. See our latest analysis for First Watch Restaurant Group. Against that latest move, the 7 day share price return of 6.49% and 30 day share price return of 7.28% sit alongside a year to date share price return of...

The fact that multiple Loar Holdings Inc. ( NYSE:LOAR ) insiders offloaded a considerable amount of shares over the...

As the United States stock market begins February on a high note, with major indices like the Dow Jones and S&P 500 showing significant gains, investors are closely monitoring opportunities amidst fluctuating economic indicators. In this environment of heightened market activity and shifting economic policies, identifying undervalued stocks can be crucial for those looking to capitalize on potential discounts in the market.

As February begins, the U.S. stock market has shown a robust start with major indexes like the Dow Jones Industrial Average and S&P 500 ending sharply higher. For those looking to invest in smaller or newer companies, penny stocks—despite their name's vintage feel—can still offer surprising value. This article explores three penny stocks that demonstrate financial strength and potential for long-term growth, offering an intriguing opportunity for investors seeking to diversify their...

As February 2026 begins, major U.S. stock indexes have surged, with the Dow Jones Industrial Average gaining 515 points and the S&P 500 nearing a record high, reflecting investor optimism amid recent economic developments. In this buoyant market environment, dividend stocks can offer a compelling opportunity for investors seeking steady income and potential growth, especially as companies continue to navigate evolving trade dynamics and economic policies.

InMode (NasdaqGS:INMD) confirmed it received a non binding proposal from Steel Partners Holdings L.P. to acquire a majority stake. The board has formed an independent committee to evaluate this proposal and consider a range of potential alternatives. The review process is underway and could result in a change of control or other significant outcomes for existing shareholders. InMode focuses on medical devices for aesthetic and wellness procedures, an area that sits at the intersection of...

If you are wondering whether Central Bancompany's current share price lines up with its underlying value, you are not alone. The stock last closed at US$24.52, with returns of 1.9% over 7 days, 2.9% over 30 days, 2.8% year to date and 89.2% over 1 year, plus 99.0% over 3 years and 142.0% over 5 years. Recent attention on Central Bancompany has centered on its share price performance and how it fits into investors' views on regional bank stocks. This has put more focus on whether the current...